Shandong Sinobioway Biomedicine Co Ltd Total Assets
Shandong Sinobioway Biomedicine Co Ltd total assets. Based on the latest financial reports, Shandong Sinobioway Biomedicine Co Ltd (002581) holds total assets worth CN¥2.05 Billion CNY (≈ $299.29 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market cap of Shandong Sinobioway Biomedicine Co Ltd for the company's overall valuation and market capitalisation.
Total Assets of Shandong Sinobioway Biomedicine Co Ltd (2007–2025)
Total assets of Shandong Sinobioway Biomedicine Co Ltd from 2007 to 2025. This chart illustrates how Shandong Sinobioway Biomedicine Co Ltd's total assets have evolved over time, based on quarterly financial data. See Shandong Sinobioway Biomedicine Co Ltd stock price for real-time trading data and today's change.
Shandong Sinobioway Biomedicine Co Ltd - Asset Composition Analysis
Shandong Sinobioway Biomedicine Co Ltd Total Assets Breakdown (December 2025)
Shandong Sinobioway Biomedicine Co Ltd total assets breakdown as of December 2025. Shandong Sinobioway Biomedicine Co Ltd's total assets of CN¥2.05 Billion consist of 29.0% current assets and 71.0% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 10.2% |
| Accounts Receivable | CN¥266.47 Million | 12.3% |
| Inventory | CN¥93.25 Million | 4.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥98.54 Million | 4.5% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2007–2025)
This chart illustrates how Shandong Sinobioway Biomedicine Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Shandong Sinobioway Biomedicine Co Ltd to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shandong Sinobioway Biomedicine Co Ltd's current assets represent 29.0% of total assets in 2025, a decrease from 58.9% in 2007.
- Cash Position: Cash and equivalents constituted 10.2% of total assets in 2025, down from 20.2% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 1.0% in 2007.
- Asset Diversification: The largest asset category is accounts receivable at 12.3% of total assets.
Shandong Sinobioway Biomedicine Co Ltd Competitors by Total Assets
Key competitors of Shandong Sinobioway Biomedicine Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
Sandoz Group AG
SW:SDZ
|
Switzerland | CHF22.86 Billion |
|
H Lundbeck A/S
CO:HLUN-B
|
Denmark | Dkr54.01 Billion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Viyash Scientific Limited
NSE:SEQUENT
|
India | Rs17.26 Billion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥5.11 Billion |
Shandong Sinobioway Biomedicine Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.64 | 8.68 | 3.30 |
| Quick Ratio | 3.65 | 7.88 | 2.96 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥493.38 Million | CN¥625.37 Million | CN¥442.58 Million |
Shandong Sinobioway Biomedicine Co Ltd - Advanced Valuation Insights
This section examines the relationship between Shandong Sinobioway Biomedicine Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.99 |
| Latest Market Cap to Assets Ratio | 0.19 |
| Asset Growth Rate (YoY) | -1.3% |
| Total Assets | CN¥2.17 Billion |
| Market Capitalization | $404.50 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shandong Sinobioway Biomedicine Co Ltd's assets below their book value (0.19x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Shandong Sinobioway Biomedicine Co Ltd's assets decreased by 1.3% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Shandong Sinobioway Biomedicine Co Ltd (2007–2025)
The table below shows the annual total assets of Shandong Sinobioway Biomedicine Co Ltd from 2007 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.17 Billion ≈ $317.30 Million |
-1.25% |
| 2024-12-31 | CN¥2.20 Billion ≈ $321.33 Million |
-6.04% |
| 2023-12-31 | CN¥2.34 Billion ≈ $342.00 Million |
-18.22% |
| 2022-12-31 | CN¥2.86 Billion ≈ $418.20 Million |
+3.69% |
| 2021-12-31 | CN¥2.76 Billion ≈ $403.30 Million |
+12.72% |
| 2020-12-31 | CN¥2.44 Billion ≈ $357.77 Million |
-28.38% |
| 2019-12-31 | CN¥3.41 Billion ≈ $499.57 Million |
-20.48% |
| 2018-12-31 | CN¥4.29 Billion ≈ $628.26 Million |
+7.41% |
| 2017-12-31 | CN¥4.00 Billion ≈ $584.91 Million |
+48.73% |
| 2016-12-31 | CN¥2.69 Billion ≈ $393.27 Million |
+11.25% |
| 2015-12-31 | CN¥2.42 Billion ≈ $353.50 Million |
+213.95% |
| 2014-12-31 | CN¥769.49 Million ≈ $112.60 Million |
-0.56% |
| 2013-12-31 | CN¥773.80 Million ≈ $113.23 Million |
+6.14% |
| 2012-12-31 | CN¥729.02 Million ≈ $106.68 Million |
+5.63% |
| 2011-12-31 | CN¥690.19 Million ≈ $101.00 Million |
+229.16% |
| 2010-12-31 | CN¥209.68 Million ≈ $30.68 Million |
+27.12% |
| 2009-12-31 | CN¥164.95 Million ≈ $24.14 Million |
+14.92% |
| 2008-12-31 | CN¥143.53 Million ≈ $21.00 Million |
+50.23% |
| 2007-12-31 | CN¥95.54 Million ≈ $13.98 Million |
-- |
About Shandong Sinobioway Biomedicine Co Ltd
Shandong Sinobioway Biomedicine Co., Ltd. engages in the pharmaceutical manufacturing industry in China. It offers injectable mouse nerve growth factor, human interferon, vaccines, traditional Chinese medicine decoction pieces, and pharmaceutical distribution. The company was founded in 1998 and is based in Shenzhen, China. Shandong Sinobioway Biomedicine Co., Ltd. is the subsidiary of Shenzhen Y… Read more